newsfilter
← Latest News
GlobeNewswire·

Oyster Point Pharma Announces Operating Expense Streamlining Plan

Plan to Continue to Drive TYRVAYA® Launch with Approximately 150-200 Field-Based Sales Resources Plan Expected to Deliver Expense Savings of Approximately $6-8 Million in the Second Half of 2022 and $40-48 Million in 2023 Company to Refocu